TOP1 (DNA topoisomerase I)

symbol:
TOP1
locus group:
protein-coding gene
location:
20q12
gene_family:
alias symbol:
None
alias name:
Scl-70 antigen
entrez id:
7150
ensembl gene id:
ENSG00000198900
ucsc gene id:
uc002xjl.4
refseq accession:
NM_003286
hgnc_id:
HGNC:11986
approved reserved:
1989-02-23
20q12

TOP1(拓扑异构酶I,Topoisomerase I)是一种关键的DNA代谢酶,属于拓扑异构酶家族(Topoisomerase family),该家族通过暂时切断DNA链以调节其超螺旋状态,从而参与DNA复制、转录和修复等过程。TOP1的主要功能是催化DNA单链的断裂和重新连接,通过形成短暂的“切割复合物”来释放DNA的扭转应力,确保遗传信息的准确传递。其作用位点集中在DNA的磷酸二酯键,尤其活跃于转录活跃区域或复制叉附近。若TOP1发生突变(如活性位点突变),可能导致DNA断裂无法修复,引发基因组不稳定,甚至与癌症(如结直肠癌)或神经退行性疾病相关。TOP1的过表达常见于多种肿瘤,因其促进癌细胞快速增殖所需的DNA解旋,但也会增加化疗药物(如伊立替康)的靶向性,这类药物通过稳定TOP1-DNA复合物导致癌细胞凋亡。相反,TOP1表达降低可能影响正常细胞的DNA修复能力,导致发育缺陷或加速衰老。TOP1家族成员(如TOP2)均具有相似的DNA解旋机制,但TOP1仅作用于单链,而TOP2切割双链。该家族共性为依赖酪氨酸残基暂时与DNA共价结合,形成可逆的“酶-DNA中间体”。此外,TOP1的活性受细胞内氧化状态及表观遗传修饰(如乙酰化)调控,其异常表达还可能干扰其他基因(如p53)的功能,间接影响细胞周期或凋亡通路。

中文English

这个基因编码的DNA拓扑异构酶,控制和转录期间改变DNA的拓扑状态的酶。这种酶催化的瞬断和再结合的DNA的单链,允许丝穿过彼此,从而改变DNA的拓扑结构。该基因定位于20号染色体,并且具有驻留在[由RefSeq的,2008年7月提供]染色体1和22假

TOP1基因的碱基序列:[NCBI]
Loading Gene Browser...
蛋白质序列
1MSGDHLHNDS QIEADFRLND SHKHKDKHKD REHRHKEHKK
41EKDREKSKHS NSEHKDSEKK HKEKEKTKHK DGSSEKHKDK
81 HKDRDKEKR KEEKVRASGD AKIKKEKENG FSSPPQIKDE
121PEDDGYFVPP KEDIKPLKRP RDEDDADYKP KKIKTEDTKK
161E KKRKLEEE EDGKLKKPKN KDKDKKVPEP DNKKKKPKKE
201EEQKWKWWEE ERYPEGIKWK FLEHKGPVFA PPYEPLPENV
241KF YYDGKVM KLSPKAEEVA TFFAKMLDHE YTTKEIFRKN
281FFKDWRKEMT NEEKNIITNL SKCDFTQMSQ YFKAQTEARK
321QMS KEEKLK IKEENEKLLK EYGFCIMDNH KERIANFKIE
361PPGLFRGRGN HPKMGMLKRR IMPEDIIINC SKDAKVPSPP
401PGHK WKEVR HDNKVTWLVS WTENIQGSIK YIMLNPSSRI
441KGEKDWQKYE TARRLKKCVD KIRNQYREDW KSKEMKVRQR
481AVALY FIDK LALRAGNEKE EGETADTVGC CSLRVEHINL
521HPELDGQEYV VEFDFLGKDS IRYYNKVPVE KRVFKNLQLF
561MENKQP EDD LFDRLNTGIL NKHLQDLMEG LTAKVFRTYN
601ASITLQQQLK ELTAPDENIP AKILSYNRAN RAVAILCNHQ
641RAPPKTF EK SMMNLQTKID AKKEQLADAR RDLKSAKADA
681KVMKDAKTKK VVESKKKAVQ RLEEQLMKLE VQATDREENK
721QIALGTSK L NYLDPRITVA WCKKWGVPIE KIYNKTQREK
761FAWAIDMADE DYEF
结构预测来自 AlphaFold DB(UniProt: P11387),颜色表示 pLDDT 置信度(深蓝高、黄橙低)。
TOP1基因的碱基突变:           仅显示部分snp
rs15476       rs1041953       rs1042234       rs1042366       rs1061982       rs1980456       rs2235362       rs2294975       rs3092210       rs3180629       rs3180630       rs3833886       rs4142394       rs4142395       rs4142396       rs6016513       rs6016514      

TOP1基因在不同组织中的表达:    [UniProt]

基因在不同组织中的表达图
正向引物序列
正向Tm值
反向引物序列
反向Tm值
评分
ATCAACTGTAGCAAAGATGCC
59
AACCTTGTTATCATGCCGGA
59
TGTAGCAAAGATGCCAAGG
58
CCAAGTAACCTTGTTATCATGC
57
CAACTGTAGCAAAGATGCC
57
GTAACCTTGTTATCATGCCG
57
转录因子
影响基因
影响类型
参考文献链接(PubMed)
CEBPB
TOP1
Unknown

TOP1基因(以及对应的蛋白质)的细胞分布位置:

[UniProt]     [GenomeNet]

" d="M482.414,245.296c3.539,4.293,4.455,10.009,0.202,11 c-4.244,0.996-4.983-10.983-8.293-8.438c-5.271,4.08,9.834,12.271,5.144,17.287c-3.717,3.607-6.172-5.75-10.839-1.976 c-4.673,3.776,6.781,7.299,2.831,11.326c-4.354,4.045-6.979-1.449-9.837-5.517c-1.193-1.742-2.059-3.851-3.595-2.748 c-1.516,1.078-1.854,1.795-0.938,3.666c2.374,4.854,9.235,10.119,5.156,12.535c-5.636,3.346-5.044-8.871-9.426-7.574 c-4.388,1.291,2.557,10.66-1.245,11.141c-4.089,0.545-3.483-10.239-6.979-8.575c-2.522,1.206-0.929,3.071-0.938,4.899 c0.004,1.32-0.964,3.6-2.372,4.062c-3.593,1.171-8.544-1.065-10.251-3.59c-6.04-8.93,0.396-15.997,4.639-7.015 c3.023,4.642,5.182,0.834,2.839-2.219c-1.032-1.354-4.309-5.901-0.781-7.252c2.904-1.113,4.271,1.941,5.985,4.592 c2.61,4.016,5.485,0.117,3.031-3.414c-1.828-2.633-2.74-3.803,3.156-7.42c6.405-4.369,6.52,3.869,10.077,0.646 c2.309-1.832-4.783-5.149,0.06-8.995c2.896-2.293,5.18,6.207,7.961,3.516c3.523-2.737-7.717-7.369,0.117-11.736 C473.413,240.77,480.519,242.891,482.414,245.296z"/> Extracellular space Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi Apparatus Nucleus Mitochondrion 0 1 2 3 4 5 Confidence
  • 质膜
  • 细胞质
  • 细胞外
  • 高尔基体
  • 囊泡
  • 细胞骨架
  • 内质网
  • 细胞核
  • 内体
  • 溶酶体
  • 线粒体

TOP1基因的本体(GO)信息:

GO库代码
对应的蛋白质
来源代码
GO:0000932
P11387 (UniProtKB)
IDA
GO:0001046
P11387 (UniProtKB)
IDA
GO:0003677
P11387 (UniProtKB)
IDA
GO:0003682
P11387 (UniProtKB)
IDA
GO:0003917
P11387 (UniProtKB)
IDA
GO:0003917
P11387 (UniProtKB)
IMP
GO:0003918
P11387 (UniProtKB)
IEA
GO:0005515
P11387 (UniProtKB)
IPI
GO:0005515
P11387 (UniProtKB)
IPI
GO:0005515
P11387 (UniProtKB)
IPI
GO:0005515
P11387 (UniProtKB)
IPI
GO:0005515
P11387 (UniProtKB)
IPI
GO:0005515
P11387 (UniProtKB)
IPI
GO:0005515
P11387 (UniProtKB)
IPI
GO:0005634
P11387 (UniProtKB)
IDA
GO:0005634
P11387 (UniProtKB)
IDA
GO:0005634
P11387 (UniProtKB)
IDA
GO:0005634
P11387 (UniProtKB)
IDA
GO:0005654
P11387 (UniProtKB)
IDA
GO:0005654
P11387 (UniProtKB)
TAS
GO:0005730
P11387 (UniProtKB)
IDA
GO:0005730
P11387 (UniProtKB)
IDA
GO:0006260
P11387 (UniProtKB)
IBA
GO:0006265
P11387 (UniProtKB)
IDA
GO:0006338
P11387 (UniProtKB)
IMP
GO:0007059
P11387 (UniProtKB)
IBA
GO:0007623
P11387 (UniProtKB)
IEP
GO:0012501
P11387 (UniProtKB)
NAS
GO:0016032
P11387 (UniProtKB)
IEA
GO:0016310
P11387 (UniProtKB)
NAS
GO:0016925
P11387 (UniProtKB)
TAS
GO:0031298
P11387 (UniProtKB)
IBA
GO:0032922
P11387 (UniProtKB)
IMP
GO:0040016
P11387 (UniProtKB)
IEA
GO:0042493
P11387 (UniProtKB)
IEP
GO:0043204
P11387 (UniProtKB)
IEA
GO:0044822
P11387 (UniProtKB)
IDA
GO:0044822
P11387 (UniProtKB)
IDA
GO:0000228
P11387 (UniProtKB)
IDA

可能调控 TOP1基因的相关microRNA:     

String
BioGrid
IntAct
mentha
MINT
加载中…
关联基因 作用方式 资源库来源/分值
疾病名称 关系值 NofPmids NofSnps 来源
疾病名称 关系值 NofPmids NofSnps 来源
Adverse reaction to drug 0.12 1 0 CTD_human
Glioblastoma 0.003538676 3 0 BeFree_LHGDN
Carcinosarcoma 0.00272435 1 0 LHGDN
Lung Neoplasms 0.00272435 1 0 LHGDN
Prostatic Neoplasms 0.00272435 1 0 LHGDN
Osteosarcoma 0.00272435 1 0 LHGDN
Cessation of life 0.00272435 1 0 LHGDN
Colorectal Neoplasms 0.00272435 1 0 LHGDN
Infection 0.00272435 1 0 LHGDN
Squamous Cell Neoplasms 0.00272435 1 0 LHGDN
Slx4 and Fun30/SMARCAD1 coordinate S-phase checkpoint regulation and replication fork protection in response to Top1-DNA crosslinks.
Courtes M, Boissière T, Barthe A, Pasero P, Pardo B Nucleic Acids Res IF: 15.0 2026-04-13
ATR inhibition potentiates the antitumor efficacy of HER3-DXd in HER3-positive/HR-positive breast cancer by increasing DNA damage.
Xie X, Lee J, Gi YJ, Poullikkas T, Fuson JA, Fan PD, Fukui JA, Tripathy D, Ueno NT Br J Cancer IF: 7.8 2026-07-00
Synthesis and biological evaluation of novel fused pyridopyrimidine derivatives as topoisomerase I inhibitors and as potential antitumor agents: promising results in lung, ovary and gastric cancer.
Lopez-Aguileta L, Martín-Encinas E, Knudsen BR, Tesauro C, Schirizzi A, Montanaro R, D'Alessandro R, Perrone MG, Stefanachi A, Contino M, Alonso C Eur J Med Chem IF: 6.7 2026-06-05
Topoisomerase 1-DNA complexes are preferentially recognised by a subset of anti-topoisomerase 1 autoantibodies and their corresponding B cell receptors in systemic sclerosis.
Neppelenbroek S, Wortel CM, van Rijswijck DMH, Wetzels MJAL, Kim RQ, Loof NM, Erbì M, Levarht EWN, Everts B, Heck AJR, de Vries-Bouwstra JK, Fehres CM, Toes REM, Scherer HU Ann Rheum Dis IF: 24.0 2026-08-00
Dual targeting of topoisomerase I and DNA G-quadruplexes enhances senescence and chemosensitivity in colorectal cancer.
Li Y, Ji D, Jia Y, Liang Y, Wei E, Gao C, Li Y, Zeng C, Wang L, Wang C, Guo Z, Zhang Y, Zhou MM, Wu D, Zeng L Commun Biol 2026-03-09

评论加载中...

登录后即可发表评论 登录 注册

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: product@genelibs.com